S-resistin inhibits adipocyte differentiation and increases TNFα expression and secretion in 3T3-L1 cells  by Fernández, Carmen M. et al.
Biochimica et Biophysica Acta 1803 (2010) 1131–1141
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamcrS-resistin inhibits adipocyte differentiation and increases TNFα expression and
secretion in 3T3-L1 cells
Carmen M. Fernández a,1, Araceli del Arco a,2, Nilda Gallardo a, Lidia Aguado a, María Rodriguez a,
Manuel Ros b, Jose M. Carrascosa c, Antonio Andrés a, Carmen Arribas a,⁎
a Área de Bioquímica, Centro Regional de Investigaciones Biomédicas (CRIB). Facultad de Ciencias del Medio Ambiente and Facultad de Químicas, Universidad de Castilla-La Mancha,
Av. Carlos III s/n 45071-Toledo, Spain
b Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avda. Atenas, s/n. 28922 Alcorcón, Madrid, Spain
c Centro de Biología Molecular “Severo Ochoa” UAM-CSIC, Facultad de Ciencias, Universidad Autónoma, 28049 Madrid, SpainAbbreviations: S-resistin, Short-resistin; C/EBPα, C
enhancer binding proteins α β and γ; PPARγ, Pero
receptor gamma; FAS, Fatty acid synthase; ALBP/aP2, A
CPT1, Carnitine palmitoyltransferase1; GLUT4, Glucose
transporter 1; TNFα, Tumor necrosis factor alpha;
Interleukine 1β; PAI-1, Plasminogen activity inhibitor
kappa B; DMEM, Dulbecco's modiﬁed Eagle's medium;
Conditioned medium
⁎ Corresponding author. Área de Bioquímica, Centro
Biomédicas (CRIB). Facultad de Ciencias del Medio Amb
La Mancha, Av. de Carlos III s/n 45071-Toledo, Spain. Te
+34 925268840.
E-mail address: carmen.arribas@uclm.es (C. Arribas)
1 Present address: Hospital Nacional de Parapléjico
Molecular, Finca de Perelada s/n, 45071-Toledo (Spain)
2 CIBER de Enfermedades Raras (CIBERER), Spain.
0167-4889/$ – see front matter © 2010 Elsevier B.V. A
doi:10.1016/j.bbamcr.2010.06.012a b s t r a c ta r t i c l e i n f oArticle history:
Received 9 November 2009
Received in revised form 30 June 2010
Accepted 30 June 2010
Available online 17 July 2010
Keywords:
S-resistin
Resistin
Adipogenesis
3T3-L1
Cell differentiation
TNFα
InﬂammationS-resistin is a non-secretable resistin spliced variant described in white adipose tissue fromWistar rats. Since
resistin has been implicated in adipogenesis regulation, here we have investigated the possible role of this
new isoform in this process. For that, we have studied the adipocyte development in 3T3-L1 pre-adipocyte
cell line stably expressing s-resistin and resistin. Both isoforms are able to restrain 3T3-L1 pre-adipocyte
differentiation though affecting differently the expression pattern of pro-adipogenic transcription factors
such CCAAT/enhancer binding proteins α and β (C/EBPα and C/EBPβ) and peroxisome proliferator-
activated receptor gamma (PPARγ), as well of proteins implicated in lipid metabolism such perilipin, fatty
acid synthase (FAS), adipocyte lipid binding protein (ALBP/aP2) and carnitine palmitoyltransferase1 (CPT1).
Likewise, both resistin isoforms impair insulin-stimulated glucose transport by decreasing glucose transport
4 (GLUT4) expression but to a different degree. In addition, s-resistin expressing 3T3-L1 cells display other
remarkable differences. Thus, in these cells, endogenous resistin expression falls down while tumor necrosis
factor alpha (TNFα) and interleukine 6 (IL-6) productions are increased along differentiation. These ﬁndings
indicate that s-resistin isoform also impairs adipocyte differentiation affecting the expression pattern of key
pro-adipogenic transcription factors and insulin sensitivity. Additionally, s-resistin may play a role in
inﬂammatory processes./EBPβ and C/EBPγ, CCAAT/
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Several studies have clearly established that adipocytes behave as
endocrine cells that secrete a wide variety of peptides, hormones andpro-inﬂammatory cytokines involved in fat cell signalling to other tissues
[1]. In addition, adipocytes express receptors for most of these factors,
being also target of these factors in a paracrine/autocrine manner. Many
of the fat cell signals are involved in glucose and lipid metabolism
regulation, reproduction and inﬂammation processes, among others
[2,3].
In the latest years, amember of a novel class of cysteine-rich proteins,
resistin (also called FIZZ3: Found in Inﬂammatory Zone; ADSF: Adipocyte
Secretory Factor), was demonstrated to be secreted by adipocytes [4,5].
Early studies showed that in vivo administration of recombinant resistin
impairs glucose tolerance and insulin actions in normal mice, while
administration of anti-resistin antibodies enhances the insulin sensitivity
of insulin-resistant and obese mice [5]. Moreover, it has been reported
that mice lacking resistin display low blood glucose levels after fasting
and decreased expression of gluconeogenic enzymes, suggesting a role
for resistin inmediatinghyperglycemia associatedwith obesity [6]. These
initial observations led to the hypothesis that resistin could promote
insulin resistance in different tissues, linking obesity and type 2 diabetes
[5]. Besides all these metabolic effects, in rodents, resistin has been also
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coordinated activity of pivotal transcription factors such as PPARγ and
CCAAT/enhancer binding family proteins (C/EBPβ, C/EBPδ and C/EBPα)
which are expressed during adipogenesis [7]. In both, the mice pre-
adipocitary cell line 3T3-L1 [8] and in the stroma vascular fractions of rat
fat pads [9], resistin expression is increased during the adipocyte
development and down-regulated by thiazolidinediones, a class of
insulin-sensitizing drugs known to serve as ligands for PPARγ [5,10,11].
Likewise, differentiated 3T3-L1 cells overexpressing resistin showed
increased production of pro-inﬂammatory cytokines and impaired
insulin sensitivity [12]. Therefore, taken together, these results suggested
that resistin acts as a feedback signal of adipogenesis to restrict adipose
tissue formation [9,13].
InWistar rats we have identiﬁed a novel resistin isoform, s-resistin
(short-resistin), which is expressed mainly in the white adipose
tissue. This resistin isoform is generated by alternative splicing and
lacks the signal peptide [14]. In transfected cells, s-resistin shows a
predominant nuclear distribution suggesting that it may perform
different functions from resistin. Interestingly, resistin and s-resistin
are differentially expressed depending on fat depot location, aging
and even nutritional status. These data point out that alternative
splicing plays a role in this regulation [15].
In an attempt to explore the function of resistin isoforms in the
adipogenesis, we have studied the differentiation of 3T3-L1 pre-
adipocyte cells stably expressing resistin or s-resistin. Both isoforms
interfere with the differentiation process but affecting in a different
way the expression pattern of key pro-adipogenic transcription
factors. Likewise, resistin isoforms impair in a different degree the
insulin-stimulated glucose transport. Interestingly, both isoforms
promote IL-6 and plasminogen activity inhibitor type1 (PAI-1)
secretion, but only s-resistin increases TNFα expression and secretion
in early and intermediate stages of adipocyte differentiation. Taken
together, the data indicate that the s-resistin variant carries out
additional functions during adipocyte differentiation.
2. Materials and methods
2.1. Construction of resistin and s-resistin expression plasmids
BamHI fragments containing full length cDNAs of rat resistin
isoforms fused in-framewith a FLAG epitope sequence at carboxy-end
(resistin-FLAG, 381 bp and s-resistin-FLAG, 240 bp) [14] were cloned
into the pIRES1hyg expression vector (Clonthech) BamHI-digested to
ﬁnally obtain s-res-FLAG-pIRES and res-FLAG-pIRES. Both construc-
tions were sequencedwith the ABI Prism 3700 DNA analyzer (Applied
Biosystems).
2.2. Cell culture, transfection and selection of stably transfected 3T3-L1
cells
Murine 3T3-L1 pre-adipocytes (purchased from American Type
Culture Collection, ATCC) were grown in Dulbecco's modiﬁed Eagle's
medium (DMEM) containing 10% foetal bovine serum (FBS) (Gibco
BRL) at 37 °C in a 5% CO2 atmosphere. For stable expression of the rat
resistin isoforms, the s-res-FLAG-pIRES and res-FLAG-pIRES constructs
as well as the empty vector pIRES, were used to transfect 3T3-L1 cells
with lipofectamine™ reagent (Invitrogen). Cells were incubated with
DNA–liposome complexes in serum-freemedia for 6 h. After 48 h, cells
were selected for 2 weeks in medium containing 400 μg/ml hygro-
mycin B (Calbiochem). The surviving cells were screened for resistin,
s-resistin and the hygromycin B phosphotransferase gene expression
by RT-PCR and immunoﬂuorescence assay (see below), and then
further grown in culture medium supplemented with 200 μg/ml
hygromycin B. The cell line types obtained were named 3T3-L1-res,
3T3.L1-s-res and 3T3-L1-pIRES. Secretion of resistin-FLAG fusion
protein from 3T3-L1-res cells was conﬁrmed in culture medium bystandard western blot procedures using anti-FLAG M2 antibody at
dilution 1:1000 (Sigma).
2.3. Differentiation stimulation protocol
3T3-L1 ﬁbroblast or transduced cell lines were grown and differen-
tiated into adipocytes in 6 wells culture dishes, as described [16]. Brieﬂy,
cells were grown as described above and two days after full conﬂuence,
were differentiated by incubation during 2 days in DMEM containing
25 mM glucose, 0.5 mM isobutylmethylxanthine (IBMX, Sigma), 1 μM
dexametasone (DEX, Sigma), 10 μg/ml insulin (Sigma) and 10% FBS and
then for 2 days inDMEMcontaining 25 mMglucose, 10 μg/ml insulin and
10% FBS. Next, cells were maintained (6–14 days) in the same medium
without insulin until use. For experiments with conditioned medium
(CM), culture medium from undifferentiated stably transfected 3T3-L1
cell lines was collected and centrifuged to remove cell remains (200×g;
5 min). The supernatantwas frozen at−20 °C and thawedprior to use for
adipogenesis experiments. CMs were used diluted at 50% in DMEM, as
basal medium, to differentiate 3T3-L1 pre-adipocyte cells as described
before.
2.4. Immunoﬂuorescence analysis
3T3-L1 and stably transfected 3T3-L1 cell lines were ﬁxed in 4%
paraformaldehyde in PBS for 20 min, rinsed with PBS, and incubated
with NaBH4 (1 mg/ml in PBS) for 10 min. Cells were then permea-
bilized with 0.2% Triton X-100 in PBS for 10 min and blocked in PBS,
0.2% Triton X-100, 1% bovine serum albumin for 1 h. Incubation with
the primary antibody anti-FLAG (M2 Sigma, 1:500) was performed at
room temperature for 2 h. After washing with PBS, cells were
incubated for 1 h with secondary antibody (FITC-conjugated anti-
mouse rabbit IgG; Sigma) at 1:1000. Fluorescence microscopy was
performed using an axiovert epiﬂuorescence microscope (Carl Zeiss,
Cologne, Germany) at a nominal magniﬁcation of ×63. Images were
taken in parallel and processed under identical conditions.
2.5. Oil Red O staining
10% formalin (pH 7.4)-ﬁxed 3T3-L1 cells were stained by Oil Red O
(stock solution: 3 mg/ml dissolved in isopropanol; working solution:
60% Oil Red O stock solution and 40% distilled water) for 5 min and
counterstained with hematoxylin for 1 min [17]. The lipid droplets
were visualized by bright-ﬁeld microscopy. To quantify the accumu-
lation of triglycerides, the dye was extracted from the cell cytoplasm
by addition of 1 ml of isopropanol and then absorbance wasmeasured
at 518 nm, using a Beckman DU 530 spectrophotometer.
2.6. RNA isolation and semi-quantitative RT-PCR analysis
Total RNA from 3T3-L1 cells and 3T3-L1 stably transfected cell lines
was isolated using RNA-Easy Mini Kit (Qiagen, Hilden, Germany)
following the manufacturer's instructions. Complementary DNA (cDNA)
was synthesized from 1 μg of DNase-treated RNA [18]. Quantiﬁcation of
the expression of transfected resistin isoforms was performed by semi-
quantitative polymerase chain reaction (PCR) as described previously
[18]. Speciﬁc primers complementary to rat resistin isoforms and FLAG
coding sequencewere used. For resistin-FLAG construct the primers used
were; forward R5′ (5′-CTGGATCCATGAAGAACCTTTCATTTC-3) and re-
verse Flag3′ (5′-GAGGATCCTCACTTGTCATCGTCGTCC-3′) and for s-resis-
tin-FLAG; forward S5′ (5′-CTGGATCCATGAAGAACACTGTCCATA-3′) and
reverse Flag3′. BamHI restriction sites used for cloning into the pIRES1hyg
vector are underlined. As control, mouse β-actin expression was also
determined with primers; forward β-actin-5′ (5′-GGTATG-
GAATCCTGTGGCATCCATGAAA-3′) and reverse β-actin-3′ (5′-
GTGTAAAACGCAGCTCAGTAACAGTCC-3′). Also speciﬁc primers for
hygromycin B phosphotransferase gene contained into the pIRES1hyg
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TCCAGCGAGAGCCTGACCTATTG-3′ and reverse Hg3′; 5′-CTGCTGCTCCA-
TACAAGCAAC-3′). After PCR reactions, the ampliﬁed products were
separated and analyzed in agarose gels as described previously [18].2.7. Real time q-PCR analysis
Real time quantitative PCR (q-PCR) was performed by using ABI
PRISM 7500 Fast Sequence Detection System instrument and software
(Applied Biosystem, Foster City, CA). Relative quantitation of target
cDNA in each sample was performed from 10 ng of cDNA in TaqMan
One-Step real time PCR Master Mix and using Pre-Developed TaqMan
Assay Reagents (PE Applied Biosystem) for: FAS (Mm01253292_m1),
ALBP/aP2 (Mm00445880_m1), CPT1 (Mm00487200_m1), C/EBPα
(Mm00514283_s1) , C/EBPβ (Mm00843434_s1) , PPARγ
(Mm00440945_m1), GLUT4 (Mm00436615_m1), GLUT1
(Mm01192270_m1), TNFα (Mm00443258_m1), resist in
(Mm00445641_m1), perilipin (Mm00558672_m1) and NF-κB
(Mm00476379_m1). 18S rRNA (Hs99999901_s1) with VIC as real
time reporter was used as control to normalize gene expression. The
ΔΔCT method was used to calculate the relative differences between
experimental conditions and control groups as fold change in gene
expression [19].2.8. Glucose transport activity assays
Differentiated cell lines were maintained in serum-free DMEM
medium (Gibco), for 2 hours prior to insulin stimulation. Then, cells
were incubated in the same medium with either 0 or 100 nM insulin
(Sigma) for additional 15 min at 37 °C. 2-deoxyglucose (0.2 mM)
and [
3
H]-2-deoxyglucose (1 μCi/ml) (Amersham Pharmacia Biotech)
were added to the cells and incubated during 7 min at 37 °C. Cells
were then incubated with the transport stop solution (50 μM
Cytochalasin B, 5 mM D-glucose) for 10 min at 37 °C and washed
twice in ice-cold Krebs-Ringer Hepes (KRH) buffer pH 7.4 (120 mM
NaCl, 4.75 mM KCl, 1.2 mM MgSO4, 1.2 mM CaCl2, 25 mM Hepes) to
remove extracellular label. Cells were suspended in NaOH 1 N, SDS
0.1%, at 50 °C for 2 h.
3
H radioactivity was determined by scintillation
counting using a Beckman Scintillation counter. [
3
H]-2-deoxyglucose
uptake in the absence of insulin was considered as basal glucose
transport. The small amount of unspeciﬁc [
3
H]-2-deoxyglucose
remaining was corrected from the [
3
H]-2-deoxyglucose content in
samples incubated with the transport stop solution for 10 min at
37 °C prior to the transport reaction.2.9. Pro-inﬂammatory cytokine determinations
Culture media were removed from cell line types at designated
days during differentiation process and centrifuged at 3000×g for
5 min. Supernatants were then analyzed using a mice speciﬁc ELISA
kits for TNFα (Abcam, Cambridge, UK), IL-6 and IL-1β (BioVendor,
Modrice, Czech Republic) and PAI-1 (Innovative Research, USA)
following the manufacturer's instructions.2.10. Statistical analysis
Statistical analysis was performed using one-way ANOVA
(GraphPad Prism 3.03 software, GraphPad Software, Inc., San
Diego, CA). When the main effect was signiﬁcant, the Bonferroni
post hoc test was applied to determine individual differences
between means. P values less than 0.05 were considered to be
statistically signiﬁcant.3. Results
3.1. Generation and characterization of 3T3-L1 cells stably expressing rat
resistin isoforms
To study the long-term physiological effects of resistin isoforms on
adipocyte differentiation, we have generated 3T3-L1 cells lines stably
transfected with both spliced variants. In order to do that, resistin and s-
resistin rat isoforms were tagged with the FLAG epitope at the carboxy-
end and expressed from a bicistronic expression vector (pIRES) (Fig. 1A).
The 3T3-L1 clonal cell lines ﬁnally obtained, named as 3T3-L1-res
(resistin), 3T3-L1-s-res (s-resistin) and 3T3-L1-pIRES (empty vector),
have been analysed to select those with low copy number of integrated
plasmid and equivalent expression levels. Southern blots analyses have
conﬁrmed that the selected stably transfected cells have inserted a single
copy of exogenous constructs (not shown) and, therefore, they could be a
reliable system similar to physiological conditions. Expressions of resistin
FLAG-tagged constructs have been analysed by RT-PCR with speciﬁc
oligonucleotides (Fig. 1B). In addition, intracellular distributionof resistin-
FLAG and s-resistin-FLAG proteins has been analysed by immunoﬂuores-
cence with anti-FLAG antibodies. Thus, as it has previously been shown
[14], res-FLAG exhibits the pattern characteristic for a secretion protein,
with intense signals in endoplasmic reticulum and trans-Golgi network,
whereas s-res-FLAG is locatedmainly into thenucleus (Fig. 1C).Moreover,
the secretion of resistin-FLAGprotein has been conﬁrmed in supernatants
from 3T3-L1-res cells by Western blot (Fig. 1D).
The stably transfected 3T3-L1 clones, 3T3-L1-res, 3T3-L1-s-res, and
3T3-L1-pIRES as control have been differentiated to fully adipocytes using
standard protocols. The differentiation processwas carried on for 14 days.
To conﬁrm the correct development of adipogenesis, we have evaluated
the morphological changes that take place in the course of the process.
Thus, cells have been stained at day 0, previous to inductors addition, and
at day 14 after induction, using the neutral lipid stain Oil Red O. Prior to
stimulation (day 0), 3T3-L1-res and 3T3-L1-s-res cells already contain
small lipid droplets in the cytoplasm compared with control cells, which
present a clear cytoplasmwithout lipid drops. Regardless of the existence
of lipid depots prior to stimulation, 3T3-L1-res and 3T3-L1-s-res cells, like
control 3T3-L1-pIRES cells, show in this early stage the ﬁbroblastic
morphology characteristic of undifferentiated cells. At the end of
differentiation process (day 14), control cells have acquired a rounded
morphology common to mature adipocytes with large lipid droplets that
surrounded the nucleus (Fig. 2A). However, this trait is not observed in
3T3-L1-res and 3T3-L1-s-res cells, most of which preserve a ﬁbroblastic
morphology where the lipids are dispersed in the cytoplasm into small
droplets (Fig. 2B).
Next we have investigated whether this anomalous lipid organi-
zation is concomitant with quantitative differences in the total lipid
content. The stain agent was extracted from cells with isopropanol
before (day 0) and after differentiation (day 14) and quantiﬁed as
described in materials and methods section. In agreement with the
morphologic pattern observed prior to stimulation, the lipid content
at day 0 was in 3T3-L1-res and 3T3-L1-s-res cells signiﬁcantly higher
than in control cells (35% and 30%, respectively, Pb0,05) (Fig. 2C). This
result conﬁrms that 3T3-L1-res and 3T3-L1-s-res cells, in pre-
adipocytary stage, are already able to accumulate lipids. Although
all cell lines showed a gain in total lipid content at the end of the
differentiation process respect to day 0 (103% for 3T3-L1-s-res and
125% for 3T3-L1-pIRES), the increase observed in 3T3-L1-res (152%,
Pb0.001) was signiﬁcantly higher than those observed in the others
cell types analyzed (Fig. 2C). Adipocyte lipid droplets are triacylgly-
cerol depots and perilipin is a protein that constitutively associates
with these structures. This protein restricts the access of cytosolic
lipases and promotes triacylglicerol storage, playing a key role in
triacylglycerol accumulation and lipid droplet formation [20]. Thus,
we also have explored its expression pattern along the differentiation
process in control, resistin and s-resistin expressing 3T3-L1 cells. In
Fig. 1. Generation of 3T3-L1 cells stably expressing resistin-ﬂag isoforms. A. Schematic representation of resistin isoforms ﬂag-tagged at carboxy-end used. Exons that make up each
spliced resistin isoform and start codons are indicated. ATGs are numbered according to their position at resistin isoform. B. Analysis of exogenous gene expression by RT-PCR. Total
RNA from 3T3-L1-res (res), 3T3-L1-s-res (s-res), 3T3-L1-pIRES (Hyg) and 3T3-L1 as control (ϕ) was used to conﬁrm the expression of exogenous resistin isoforms and resistance
gene. The speciﬁc primers used to analyse each construct are indicated. As control β-actin expression is also determined. C. Subcellular localization of resistin-FLAG and s-resistin-
FLAG in 3T3-L1-res and 3T3-L1-s-res cell lines. Inmunoﬂuorescence analysis was conducted with M2 anti-FLAG antibody. Both proteins show a speciﬁc distribution, being
predominantly nuclear for s-resistin-FLAG and cytoplasmic for resistin-FLAG. Fluorescence microscopy was performed at a nominal magniﬁcation of ×63. Images were taken in
parallel and processed under identical conditions. D. resistin-FLAG protein secretion (indicated by an arrow) was detected byWestern blot analysis of proteins from supernatants of
3T3-L1-res cells using M2 anti-FLAG antibody (* unspeciﬁc signal).
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3T3-L1-res and 3T3-L1-s-res, our results show an ~80-fold lower
induction of the perilipin expression in these cell lines compared with
control cells, at day 6 of differentiation when the adipocytary
characteristics have already been acquired (Fig. 2D).
3.2. Effects of resistin isoforms on expression of genes involved in lipid
metabolism
Given that 3T3-L1 cells expressing stably resistin isoforms
presented alterations in lipid accumulation, we examined the
expression during adipogenesis of genes related to lipid metabolism
such as FAS, ALBP/aP2 and CPT1 genes. In this case, the differentiation
protocol was maintained until day 6 post-induction since previous
analysis have demonstrated that at this time all competences at
molecular level have been acquired [21,22]. Cells were harvested prior
(day 0) and after (days 2, 4 and 6) induction and RNA was extracted
for gene expression analysis by q-PCR. As shown in Fig. 3A, initially
(day 0) both, resistin and s-resistin 3T3-L1 cells, present slightly
higher levels of FAS messenger than 3T3-L1-pIRES. This result couldaccount for the lipid accumulation observed at day 0 in both cell lines
(Fig. 2). FAS expression increased in both groups of transfected cells
during late differentiation but to a lesser extent than control cells. In
contrast, we have detected notable differences in the expression of
ALBP/aP2 and CPT1 between 3T3-L1-s-res and 3T3-L1-res cells. Thus,
in agreement with previous results [12], ALBP/aP2 expression is
induced in 3T3-L1-res cells during differentiation in the same way
that in control cells although its expression diminishes in the late
stages. However, s-resistin transfected cells show higher levels of
ALBP/aP2 mRNA than 3T3-L1-res and control cells throughout the
adipogenesis stages (Pb0,001) (Fig. 3B). Also, in contrast with 3T3-L1-
res and control cells, 3T3-L1-s-res shown increased expression levels
of CPT1 in early differentiation stages (Fig. 3C).
3.3. S-resistin isoform changes the expression pattern of transcription
factors involved in early adipogenesis
Adipogenesis is characterized by chronological changes in the
expression pattern of numerous genes that lead to the establishment
of the differentiated stage. Early key regulatory events of
Fig. 2.Morphologic analysis and lipid content determination in 3T3-L1-res and 3T3-L1-s-res cells duringdifferentiationprocess. A. 3T3-L1-res, 3T3-L1-s-res and control 3T3-L1-pIRES cells
were induced to differentiate to fully adipocytes for 14 days. The cells were ﬁxed and stained with Oil Red O to visualize the lipid content. Representative images of Oil Red O staining are
shown for eachcell lineatmagniﬁcation×10 (atday0, above)and×40 (atday14, below).B.Morphologicdetail of the differentiated cell lines showingdifferences in lipiddistribution. Scale
bar, 20µm. C. The stainwas extractedwith isopropanol fromOil RedO treatedcells and its absorptionwasquantiﬁedat518 nm.Valuesaremeans±SEMof 4-5 separate determinationsper
group of cells and day. *Pb0.05 versus 3T3-L1-pIRES control cells at day 0. aPb0.001 versus 3T3-L1-pIRES control cells at day 14. D. Total RNA from cell line types, before (day 0) and after
(day6)differentiation,was isolatedasdescribedbyFig. 3, andperilipin expressionwasdeterminedbyq-PCR. Valuesaremeans±SEMof4–5 separatedeterminationsper groupof cells and
day. **Pb0.001 versus 3T3-L1-pIRES control cells at day 0. *Pb0.05 versus 3T3-L1-s-res cells at day 0.
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EBPβ and C/EBPδ which modulate synergistically the expression of
PPARγ and C/EBPα acting on the C/EBP element present in its
promoter [23]. To investigate whether resistin isoforms could affect
differently the time-course expression of these transcription factors,
we have analyzed the expression of C/EBPβ and C/EBPα as well as
PPARγ during adipogenesis in 3T3-L1-res, 3T3-L1-s-res and control
cell lines. Cells were differentiated as described above and expression
of the transcription factors has been analyzed by q-PCR. As shown in
Fig. 4, control cells, 3T3-L1-pIRES, exhibit the expected expression
pattern, with C/EBPβ expression increasing early at day 2 and
declining later in parallel with the increase of C/EBPα and PPARγ
expression, from days 2 to 6 (Fig. 4A–C). On the other hand, 3T3-L1-
res and 3T3-L1-s-res cells display remarkable differences in this
temporal expression proﬁle. Thus, before inductors addition (day 0)
both, 3T3-L1-res and 3T3-L1-s-res cells, presented higher C/EBPβ and
PPARγ expression levels than control cells (Fig. 4A and B). Neverthe-
less, 3T3-L1-res cells, but not 3T3-L1-s-res, showed an increase in the
expression of C/EBPβ and PPARγ at day 2, although were unable to
continue increasing PPARγ levels, which declined from the day 2 of
the adipoconversion process (Fig. 4A and B). In 3T3-L1-s-res cells C/
EBPβ levels decline gradually from day 0 (Fig. 4A). Likewise, in these
cells, the expected induction of PPARγ expression at day 2 is not
observed, remaining its expression scarcely detectable during adipo-
cyte differentiation (Fig. 4B). Finally, in our experimental conditions C/EBPα expression remains almost undetected in 3T3-L1-res and 3T3-L1-s-
res cells (Fig. 4C). Thus, in 3T3-L1-s-res cells, regardless of the increase in
C/EBPβ expression previous to differentiation,mRNA levels of PPARγ, the
adipogenesis headmaster gene, appears clearly diminished since early
differentiation stages (Fig. 4B).3.4. S-resistin impairs insulin sensitivity in 3T3-L1
Previous studies have shown that resistin is an adipocyte factor
that impairs insulin action and glucose tolerance [5,6]. Therefore, we
have examined whether the s-resistin isoform could also affect
insulin-stimulated glucose transport in these cells. To check this,
3T3-L1-res, 3T3-L1-s-res and 3T3-L1-pIRES cells, were differentiated
to adipocytes and insulin-stimulated glucose transport was analyzed
by measuring the uptake of [3H]-2-deoxy-D-glucose in presence or
absence of insulin (100 nM). Our data, shown in Fig. 5A, indicate that
both cell types exhibit lower capacity for glucose uptake than control
cells. Thus, 3T3-L1-res and 3T3-L1-s-res presented a signiﬁcantly
lower basal glucose transport, though in a different degree (90% and
56%, respectively), respect to 3T3-L1-pIRES cells. Besides, maximal
insulin stimulation of glucose uptake in cells expressing both resistin
and s-resistin isoformswas alsomuch lower (84% and 53% in 3T3-L1-res
and 3T3-L1-s-res, respectively) than control 3T3-L1-pIRES cells
(Fig. 5A).
Fig. 3. Effect of resistin isoforms on the expression of lipid metabolism related genes
during adipogenesis. Stably transfected 3T3-L1 cell lines were differentiated to fully
adipocytes. Cells were harvested at day 0, before induction and reaching 100%
conﬂuence, and at days 2, 4 and 6 after application of the differentiation induction
protocol. Total RNA was isolated from the different cell lines and the expression of
mouse FAS (A), ALBP/aP2 (B) and CPT1 (C) genes was determined by q-PCR. Values are
means±SEM of 4–5 separate determinations per group of cells and days. *Pb0.05 and
**Pb0.001 for 3T3-L1-res and 3T3-L1-s-res cells versus 3T3-L1-pIRES control cells at
the same day.
Fig. 4. Resistin isoforms alter the expression of early transcription factor during
adipogenesis. Expressions of mouse transcription factors genes C/EBPβ (A), PPARγ (B)
and C/EBPα (C) were quantiﬁed by real time q-PCR from the same samples as those in
Fig. 3. Values are means±SEM of 4–5 separate determinations per group of cells and
day. *Pb0.05 and **Pb0.001 for 3T3-L1-res and 3T3-L1-s-res cells versus control cells
3T3-L1-pIRES at the same day.
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whether the decline of insulin-stimulated glucose transport could be
accounted for changes in GLUT4 gene expression. Our results, shown in
Fig. 5B, indicate that GLUT4 expression is reduced in cells expressingresistin and s-resistin. Thus, after day 4 of the adipogenesis, GLUT4mRNA
levels were reduced by 88% in 3T3-L1-res and by 63% in 3T3-L1-s-res
compared with control cells 3T3-L1-pIRES (Pb0,001). This reduction of
GLUT4 expression matches well with the diminished insulin-stimulated
glucose uptake observed in these cell lines.
3.5. S-resistin down-regulates endogenous mouse resistin expression
during 3T3-L1 differentiation
In mouse it has been reported that resistin expression is up-
regulated during early and intermediate adipogenesis but down-
regulated in late steps of adipocyte differentiation. Moreover, resistin
Fig. 5. Resistin and s-resistin affect the glucose uptake in differentiated 3T3-L1 cells. A. Differentiated 3T3-L1-res, 3T3-L1-s-res and 3T3-L1-pIRES control cells (at day 6 of
adipogenesis) were stimulated in the absence or presence of 100 nM insulin for 15 min at 37 °C, and the glucose uptake was determined by addition of [
3
H]-2-deoxyglucose. Values
are means±SEM of 4 separate triplicate determinations per group of cells. aPb0.001 versus basal transport of control cells; *Pb0.001 versus basal transport in the same cell group;
**Pb0.001 versus insulin-stimulated glucose transport of control cells. B. The expression levels of GLUT-4 were determined in 3T3-L1-res, 3T3-L1-s-res and 3T3-L1-pIRES, as control
cells, during adipogenesis by q-PCR. Values are means±SEM of 4–5 separate determinations per group of cells and day. *Pb0.05 and **Pb0.001 for 3T3-L1-res and 3T3-L1-s-res,
versus control cells, 3T3-L1-pIRES at the same day.
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mechanism [9,13,24]. Subsequently, to test whether the s-resistin variant
could also inﬂuence resistin expression, we have analyzed the levels of
endogenous resistin mRNA in our cell lines. In agreement with previous
reports [9,24], our data indicate that in control cells endogenous
expression of resistin appears increased from the early stages of
adipogenesis (Fig. 6A).However, adifferent expressionpattern isobtained
in 3T3-L1-res and 3T3-L1-s-res cells. Thus, 3T3-L1-res cells showan initial
increase ofmouse resistinmRNA. These cells seem tobe unable to support
these expression levels that fall down by 84%with respect to control cells
in subsequent stages (Fig. 6A). Interestingly, 3T3-L1-s-res cells present
almost undetectable levels of endogenous resistin expression (approx. 6–
10% of the expression levels of control cells) along the whole
adipoconversion process (Fig. 6A).
3.6. Effect of resistin isoforms in pro-inﬂammatory cytokine production
during differentiation process of 3T3-L1 cells
In 3T3-L1 cells, it has been described that resistin increases the
production of pro-inﬂammatory cytokines [12]. Therefore, we exam-
ined the possible inﬂuence of resistin isoforms on TNFα, IL-6, IL-1β and
PAI-1 production during 3T3-L1-cells adipogenesis. Quantiﬁcation of
TNFα levels in supernatants from these cell lines during the
differentiation showed that 3T3-L1-s-res cells secreted 2–4 times
more TNFα than the others cell types along the differentiation process
(Fig. 7A). This result correlates well with the TNFα expression pattern
from cell lines shown in Fig. 6B. Thus, whereas 3T3-L1-res and control
cells present undetectable TNFα mRNA levels throughout all differ-entiation stages analyzed, 3T3-L1-s-res cells display a signiﬁcantly
higher level at day 0 (prior to induction, Pb0.05) which keeps on
increasing along the differentiation process (Fig. 6B). Also, since early
stages, 3T3-L1-s-res cells exhibit high levels of IL-6. An increase in this
parameter is also observed at the end of adipogenesis in 3T3-L1-res
cells (Fig. 7B). On the other hand, PAI-1 production decreases along
differentiation in control cells. In 3T3-L1-res this parameter remains
high along the differentiation process. In the case of 3T3-L1-s-res,
levels of PAI-1 are lower than those of 3T3-L1-res and control cells at
early stages and remain along the differentiation (Fig. 7C). Moreover,
we also examined the production of IL-1β in cell lines but no changes
have been observed during adipogenesis (data not shown).
3.7. Conditioned medium from 3T3-L1-s-res cells inhibits adipocyte
differentiation in 3T3-L1 cells
In order to further study the possible effects that resistin and s-
resistin may exert on the differentiation process, culture media from
undifferentiated 3T3-L1-s-res and 3T3-L1-res and control cells were
harvested and used in a 50% with DMEM medium, as conditioned
media (CM) during 3T3-L1 adipocyte differentiation. Morphologic
analysis andOil RedO staining showed thatmost cells differentiated to
fully adipocytes when they were maintained in CM from control cells
(Fig. 8). Moreover, in agreementwith previous results [9], cells treated
with conditioned media from 3T3-L1-res showed inhibition of
adipocyte differentiation, preserving a ﬁbroblastic morphology and
with small lipid droplets respect to the control cells. This result
suggests that the extra resistin content present in the culture media
Fig. 6. Effect of rat s-resistin isoform on endogenous resistin and TNFα expression
during adipogenesis. A. Expression of endogenous mouse resistin gene was determined
thought the differentiation process in stably transfected 3T3-L1 cell lines by q-PCR.
Cells were harvested and RNA samples processed as in Fig. 3. Values are means±SEM
of 4–5 separate determinations per each group of cells and day. *P 0.05 and **Pb0.001
for, 3T3-L1-res and 3T3-L1-s-res cells, versus control cells, 3T3-L1-pIRES at the same
days. B. Analysis by q-PCR of TNFα expression in cell lines subjected to differentiation
protocol. **Pb0.001 for 3T3-L1-s-res versus itself in previous days.
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when 3T3-L1 cells were maintained in CM from 3T3-L1-s-res, clearly,
inhibition of adipocyte differentiation was observed (Fig. 8). Since s-
resistin is a non-secreted protein, it is possible that this inhibitory
effect could be exercised through the cytokine secreted by these cells.
4. Discussion
The hormone resistin is secreted from the adipose tissue to the
plasma where it exerts its effects on glucose metabolism and insulin
sensitivity in target tissues, such as liver, muscle and hypothalamus.
Also, resistin exerts a paracrine/autocrine effects on adipose tissue,
where it has been involved in the regulation of adipocyte develop-
ment. Resistin promotes adipocyte differentiation in early stages, but
impairs this process during late adipogenesis by a feedback
mechanism [9,13]. We have characterized a novel spliced resistin
isoform in rat, s-resistin, which shows preferential nuclear location
[14]. In an attempt to gain further insight about the cellular functions
of this non-secretable isoform, we have analyzed its effect on
adipocyte differentiation.
Our data indicate that s-resistin expression, like resistin [9,24],
is able to induce a certain adipocyte-like state in 3T3-L1ﬁbroblasts as deduced from the initial increase in lipid content
and FAS expression but impairs subsequent adipocyte differenti-
ation affecting, in a different way that resistin, the expression
proﬁle of key transcription factors related with the early
adipogenesis control. Both 3T3-L1-res and 3T3-L1-s-res cells
present high levels of C/EBPβ and PPARγ expression before
differentiation and, remarkably, in both cell lines C/EBPα
expression remains undetectable. Besides these common features,
3T3-L1-s-res and 3T3-L1-res present some differences along the
differentiation process. Thus, although 3T3-L1-res cells respond
correctly to inductors, they are unable to keep PPARγ levels that
declined below those of control cells from day 4 of differentiation.
In contrast, in 3T3-L1-s-res cells C/EBPβ and PPARγ mRNAs
declined until basal levels at day 4 and did not increase PPARγ
expression in response to hormonal inductors. The requirement of
PPARγ and C/EBPα in adipocyte differentiation has been largely
demonstrated, but they play different roles in this process
[8,25,26]. Following the early fall of C/EBPβ levels, PPARγ is
absolutely required, acting as a master regulator of adipogenesis,
while C/EBPα plays a more auxiliary role, keeping PPARγ levels
and insulin sensitivity in differentiated adipocytes [27]. Therefore,
it is possible that the deﬁcient C/EBPα expression prevents these
cells to be able to reach and sustain the required PPARγ levels for
a proper adipocyte differentiation.
Since C/EBPα and PPARγ regulate the expression of multiple genes
that control the acquisition of adipocyte phenotype and insulin
sensitivity [8,25], as expected, 3T3-L1-s-res cells exhibited alterations
in these process. Thus, 3T3-L1-s-res cells show decreased basal and
insulin-stimulated glucose transport with a concomitant fall in the
levels of GLUT4 mRNA respect to control cells. In agreement with
previously reported results [12], we also found that resistin induced a
more pronounced effect. Besides, supporting the lower basal glucose
uptake observed in cells expressing the resistin isoforms, GLUT1mRNA
levels are clearly diminished in both, 3T3-L1-res and 3T3-L1-s-res,
respect to control cells at the end of adipogenesis (data not shown). In
agreementwith these results, it has been reported that PPARγdepletion
results in a decreased insulin-stimulated glucose transport into 3T3-L1
adipocytes due to a reduction in GLUT1 and GLUT4 transport activity
[22]. Moreover, low PPARγ levels could explain the expression levels of
endogenous resistin observed in these cells. Recently, it has been
identiﬁed in the mouse resistin gene a novel adipocyte-speciﬁc
enhancer containing a binding site for PPARγ and C/EBP factors which
synergistically activate its fat-speciﬁc expression [28]. Notably, the
expression proﬁle of mouse resistin gene observed in 3T3-L1-s-res and
3T3-L1-res cells during adipogenesis matches well with that obtained
for PPARγmRNA in each cell type. This result suggests that both resistin
isoforms could regulate its own expression through a negative feedback
loop in which PPARγ could be involved.
On the other hand, it has been described that resistin affects the
expression and secretion of pro-inﬂammatory cytokines, suchTNFα and
IL-6, linking resistin production with the inﬂammatory pathway [12].
The data presented herein clearly indicate that both resistin isoforms,
resistin and s-resistin, promote the pro-inﬂammatory cytokines
production. Although we could not detect any signiﬁcant changes in
the expression of the nuclear factor kappa B (NF-κB) (data not shown)
the higher levels of cytokines detected in cells expressing resistin
isoforms can explain some of the changes in the differentiation process
in these cells. 3T3-L1-s-res cells present an increased TNFα expression
and secretion through differentiation. Given that TNFα impairs
adipocyte differentiation, promotes insulin resistance and also acts as
a potent negative regulator of resistin expression [29,30], its increased
expression in 3T3-L1-s-res cells can explain the decreased insulin
response and endogenous resistin expression observed in these cells.
Although the amount of lipid accumulation along differentiation is
similar in the three types of cells, 3T3-L1 cells expressing resistin
isoforms, in agreement with previous data [12], preserve a certain
Fig. 7. Effect of resistin isoforms in 3T3-L1 pro-inﬂammatory cytokine production along differentiation. Secretion levels of TNFα (A), IL-6 (B) and PAI-1 (C) present in culture cell
medium from 3T3-L1-res, 3T3-L1-s-res and 3T3-L1-pIRES cells during differentiation were determined by using mice speciﬁc ELISA assays. Values are means±SEM of 2–4
independent determinations. *Pb0.001 for 3T3-L1-res and 3T3-L1-s-res, versus control cells, 3T3-L1-pIRES at the same day.
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smaller cytoplasmic lipid droplets than control cells. In addition,
several studies in human and rodent adipocytes have shown that
TNFα and IL-6 increase lipolysis in part by promoting the rapid
degradation of perilipin mRNA and protein [31,32]. Although we have
not directly measured the lipolysis in these cells, the increases of
TNFα and IL-6 expression in s-resistin cells since early stages of
adipogenesis described herein, could explain both the much lower
perilipin mRNA levels and the smaller lipid droplet size observed, at
day 6 of differentiation, compared to control cells. Moreover, the high
expression pattern of CPT1 and ALBP/aP2 in 3T3-L1-s-res support the
morphological changes observed in these cells, since CPT1 and ALBP/
aP2 promote fatty acid oxidation [33,34] and the intra cellular
movement of fatty acids during lipolysis [35], respectively.
In opposition to previous data [12], we have not detected changes
in TNFα levels in 3T3-L1-res cells. This discrepancy could be due to
differences in the expression level of exogenous resistin between both
surveys. As mentioned before, Southern blot analysis indicates that
3T3-L1-res cells have a single copy of plasmid construct integrated
(data not shown), and its resistin secretion was barely detectable.
Thus, it is possible that this low resistin production was not enough to
increase TNFα expression and secretion in the same form that has
been described in other resistin expressing cells [12]. However, in our
resistin expressing 3T3-L1 cells the secretion of another pro-
inﬂammatory cytokines such IL-6 and PAI-1 that could be responsible,
at least in part, of the decrease in its insulin response. In these sense, it
has been described that resistin attenuates multiple effects of insulin
in the main insulin-target rat tissues [36] as well as in 3T3-L1 cells,
where it markedly induces the expression of suppressor of cytokine
signalling 3 gene (SOCS-3), a known inhibitor of insulin signalling
[37]. Thus, our results indicate that 3T3-L1 cells expressing a singlecopy of resistin, although to not increase TNFα levels, presents a
signiﬁcantly decrease in its insulin response.
PAI-1 activity has been shown to play a key role in thrombus
formation upon unstable atherosclerotic plaque rupture through the
inhibition of ﬁbrin clot breakdown [38]. Interestingly, resistin induces
high PAI-1 secretion through adipogenesis in 3T3-L1 cells. Thus, this
result seems to underlie the relationship between resistin and
cardiovascular disease.
On the other hand, supernatants from 3T3-L1-s-res cells are able to
impair 3T3-L1 pre-adipocyte differentiation, suggesting that inﬂam-
matory cytokines may be responsible of this inhibition. In accordance
with this, 3T3-L1-s-res cells present high mRNA levels of ALBP/aP2, a
protein expressed in adipocytes and macrophages that links inﬂam-
matory and metabolic process [39,40]. Elevated ALBP/aP2 levels
appear associated with an augmented inﬂammation and ﬁbrosis in
fatty liver disease [41] and its inhibition ameliorates diabetes and
atherosclerosis in several mouse models [42]. Therefore, our results
suggest that s-resistin isoform may play a signiﬁcant role in the rat
adipocyte inﬂammatory responses, which have been clearly linked to
other pathological circumstances such as diabetes. Accordingly, we
have previously described the increase of s-resistin expression in
retroperitoneal adipose tissue of agedWistar rats [15]. This visceral fat
depot undergoes a marked accretion during aging. Therefore, it can be
speculated that s-resistin could contribute to the inﬂammatory
process associated to aging.
Resistin is a secretion protein that may interact in a paracrine/
autocrinemanner through its, still unidentiﬁed, receptor in the adipocyte
cell surface and, activating signal transduction cascades, restrains
differentiation to restrict adipose tissue formation [9]. Nevertheless, s-
resistin is a non-secreted protein that may act as an intracellular sensor
regulating, as an intracrine factor, the differentiation process as suggest
Fig. 8. Conditionedmedium from 3T3-L1-s-res cell line impairs 3T3-L1 adipocyte differentiation. 3T3-L1 cells were differentiated using conditionedmedium (CM) from 3T3-L1-s-res,
3T3-L1-res and 3T3-L1-pIRES undifferentiated cells and diluted at 50% in DMEM, as described in Materials and methods. At day 14 after induction, cultures were ﬁxed and stained
with Oil Red O for morphology and of lipids droplets content was visualized. Representative images of bright ﬁeld are shown at magniﬁcation 10× and 40×. Scale bar, 20 μm.
1140 C.M. Fernández et al. / Biochimica et Biophysica Acta 1803 (2010) 1131–1141the data presented in this article. These data indicate that both isoforms
could be implicated in inﬂammatory responses but in a qualitative and
quantitative different ways. Thus, s-resistin promotes TNFα expression
and secretion in 3T3-L1 cells, which, besides its inﬂammatory connection,
may contribute to limit adipocyte differentiation in addition to the effects
of resistin isoform. Further studies will be required to understand the
function and physiological signiﬁcance of this short, non-secretable,
resistin isoform.
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